blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2678334

EP2678334 - ANTI-VIRAL COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.01.2018
Database last updated on 19.07.2024
FormerThe patent has been granted
Status updated on  17.02.2017
FormerGrant of patent is intended
Status updated on  06.01.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
AbbVie Ireland Unlimited Company
70 Sir John Rogerson's Quay
Dublin 2 / IE
[2017/16]
Former [2015/11]For all designated states
AbbVie Bahamas Ltd.
Sassoon House
Shirley Street & Victoria Avenue
New Providence, Nassau / BS
Former [2014/01]For all designated states
Abbvie Inc.
1 North Waukegan Road
North Chicago, IL 60064 / US
Inventor(s)01 / DEGOEY, David A.
8649 226th Avenue
Salem Wisconsin 53168 / US
02 / KATI, Warren M.
152 Knobb Hill Lane
Gurnee Illinois 60031 / US
03 / HUTCHINS, Charles W.
31005 Prairie Ridge Road
Green Oaks Illinois 60048 / US
04 / DONNER, Pamela L.
1901 McRae Lane
Mundelein Illinois 60060 / US
05 / KRUEGER, Allan C.
7260 Presidential Drive
Gurnee Illinois 60031 / US
06 / RANDOLPH, John T.
304 Broadway Avenue
Libertyville Illinois 60048 / US
07 / PATEL, Sachin V.
1259 S. Wild Meadow Road
Round Lake Illinois 60073 / US
08 / MATULENKO, Mark A.
1875 Countryside Drive
Libertyville Illinois 60048 / US
09 / KEDDY, Ryan G.
10046 West Hendee Road
Beach Park Illinois 60087 / US
10 / JINKERSON, Tammie K.
11129 10th Avenue
Pleasant Prairie Wisconsin 53158 / US
11 / LIU, Dachun
1276 Georgetown Way
Vernon Hills Illinois 60061 / US
12 / PRATT, John K.
8210 61st Avenue
Kenosha Wisconsin 53142 / US
13 / ROCKWAY, Todd W.
34136 N. Lavender Circle
Grayslake Illinois 60030 / US
14 / MARING, Clarence J.
1228 W. Borders Drive
Palatine Illinois 60067 / US
15 / HUTCHINSON, Douglas H.
160 E. Depot Street
Antioch Illinois 60002 / US
16 / FLENTGE, Charles A.
8628 225th Avenue
Salem Wisconsin 53168 / US
17 / WAGNER, Rolf
42530 Sheridan Oaks Drive
Antioch Illinois 60002 / US
18 / BETEBENNER, David A.
220 Appley Avenue
Libertyville Illinois 60048 / US
19 / SARRIS, Kathy
1309 Andover Drive
Mundelein Illinois 60060 / US
20 / WOLLER, Kevin R.
1072 Joy Court
Antioch Illinois 60002 / US
21 / CARROLL, William A.
2325 Ridgeway Avenue
Evanston Illinois 60201 / US
22 / GAO, Yi
210 East Baltusrol Drive
Vernon Hills Illinois 60061 / US
 [2014/01]
Representative(s)Modiano, Micaela Nadia, et al
Modiano & Partners
Thierschstrasse 11
80538 München / DE
[N/P]
Former [2014/01]Modiano, Micaela Nadia
Modiano & Partners (DE)
Thierschstrasse 11
80538 München / DE
Application number, filing date12716757.524.02.2012
[2017/12]
WO2012US26456
Priority number, dateUS201161446800P25.02.2011         Original published format: US 201161446800 P
[2014/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012116257
Date:30.08.2012
Language:EN
[2012/35]
Type: A1 Application with search report 
No.:EP2678334
Date:01.01.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 30.08.2012 takes the place of the publication of the European patent application.
[2014/01]
Type: B1 Patent specification 
No.:EP2678334
Date:22.03.2017
Language:EN
[2017/12]
Search report(s)International search report - published on:EP30.08.2012
ClassificationIPC:C07D403/14, A61K31/4184, A61K31/4164, A61P31/14
[2014/01]
CPC:
C07D403/14 (EP,CN,US); C07D401/14 (CN); A61P31/12 (EP);
A61P31/14 (EP); C07D207/16 (EP,US); C07D405/14 (CN);
C07D409/14 (CN); C07D413/14 (CN); C07D417/14 (CN);
C07D453/06 (CN); C07D491/113 (CN) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:ANTIVIRALE VERBINDUNGEN[2014/01]
English:ANTI-VIRAL COMPOUNDS[2014/01]
French:COMPOSÉS ANTIVIRAUX[2014/01]
Entry into regional phase23.08.2013National basic fee paid 
23.08.2013Designation fee(s) paid 
23.08.2013Examination fee paid 
Examination procedure23.08.2013Examination requested  [2014/01]
29.07.2014Amendment by applicant (claims and/or description)
10.02.2015Despatch of a communication from the examining division (Time limit: M06)
14.09.2015Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.11.2015Reply to a communication from the examining division
22.01.2016Despatch of a communication from the examining division (Time limit: M04)
25.05.2016Reply to a communication from the examining division
07.09.2016Communication of intention to grant the patent
04.01.2017Fee for grant paid
04.01.2017Fee for publishing/printing paid
04.01.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.02.2015
Opposition(s)02.01.2018No opposition filed within time limit [2018/09]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
23.11.2015Request for further processing filed
23.11.2015Full payment received (date of receipt of payment)
Request granted
07.12.2015Decision despatched
29.07.2014Request for further processing filed
29.07.2014Full payment received (date of receipt of payment)
Request granted
08.08.2014Decision despatched
Fees paidRenewal fee
07.02.2014Renewal fee patent year 03
13.02.2015Renewal fee patent year 04
08.02.2016Renewal fee patent year 05
07.02.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.02.2012
AL22.03.2017
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
MK22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
SM22.03.2017
TR22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
[2020/34]
Former [2020/31]HU24.02.2012
AT22.03.2017
CY22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
MK22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
SM22.03.2017
TR22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2020/28]HU24.02.2012
AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
SM22.03.2017
TR22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2020/15]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
SM22.03.2017
TR22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/44]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
MC22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/14]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SI22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2018/09]AT22.03.2017
CZ22.03.2017
DK22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/51]AT22.03.2017
CZ22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SK22.03.2017
SM22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
PT24.07.2017
Former [2017/50]AT22.03.2017
CZ22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
PL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
Former [2017/49]AT22.03.2017
CZ22.03.2017
EE22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
RO22.03.2017
RS22.03.2017
SE22.03.2017
SK22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
IS22.07.2017
Former [2017/48]CZ22.03.2017
FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
RS22.03.2017
SE22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
Former [2017/41]FI22.03.2017
HR22.03.2017
LT22.03.2017
LV22.03.2017
NL22.03.2017
RS22.03.2017
SE22.03.2017
BG22.06.2017
NO22.06.2017
GR23.06.2017
Cited inInternational search[XI]WO2010144646  (ABBOTT LAB [US], et al) [X] 1-15 * see the claims, the example, especially example 184 and the pharmacological acitivity as inhibitors of HCV replication * [I] 1-15
by applicantUS2010317568
 US2011092415
 US2011207699
 US2009076076
 US5095153
    - BUNGARD, H., DESIGN OF PRODRUGS, ELSEVIER, (1985), pages 7 - 24
    - NEVAR ET AL., SYNTHESIS, (2000), pages 1259 - 1262
    - CHONG ET AL., TETRAHEDRON: ASYMMETRY, (1995), vol. 6, pages 409 - 418
    - LI ET AL., TETRAHEDRON, (2007), vol. 63, pages 8046 - 8053
    - ALDOUS ET AL., TETRAHEDRON: ASYMMETRY, (2000), vol. 11, pages 2455 - 2462
    - MASUI ET AL., SYNLETT, (1997), pages 273 - 274
    - JING ET AL., ADV. SYNTH. CATAL., (2005), vol. 347, pages 1193 - 1197
    - SATO ET AL., SYNTHESIS, (2004), pages 1434 - 1438
    - SYNTHESIS, (2003), pages 2507 - 2510
    - PENNING ET AL., BIOORG. MED. CHEM., (2008), vol. 16, pages 6965 - 6975
    - SYNLETT, (2003), pages 1427 - 1430
    - MEYER ET AL., SYNTHESIS, (2005), pages 945 - 956
    - MEYER ET AL., SYNLETT, (2003), pages 1427 - 1430
    - SYNTHESIS, (2005), pages 945 - 956
    - TETRAHEDRON, (2003), pages 2701 - 2712
    - TET. LETT., (2003), pages 5807 - 5810
    - J. AM. CHEM. SOC., (1965), page 1353,1358
    - J. ORG. CHEM., (1972), page 4075,4076,4077
    - BIOORG. MED. CHEM. LETT., (2009), page 5684,5686
    - J. AM. CHEM. SOC, (1951), vol. 73, page 5171
    - CHARIFSON, P.S. ET AL., J. MED. CHEM., (2008), vol. 51, pages 5243 - 5263
    - PATEL ET AL., J MEDICINAL CHEMISTRY, (2006), vol. 49, no. 25, page 7450
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.